Coronavirus Treatment for covid-19 patients will be tested in CDMX

A study for the medical care of Covid will begin in four hospitals. Photo: Cuartoscuro / Archive

MEXICO CITY.

As of February 18, with a population of 1,666 patients, the Medical Services of Mexico City will initiate a study for the medical care of the Covid based on the drug, Remdesivir, in four hospitals.

Oliva López Arellano, Secretary of Health of Mexico City detailed in a virtual conference that the medical facilities that will participate in this study are the “Salvador Zubirán” National Institute of Medical Sciences and Nutrition, the Temporary COVID Unit of Citibanamex, the General Hospital Ajusco Medio and the General Hospital “Enrique Cabrera”.

In this regard, José Alejandro Ávalos Bracho, general director of Provision of Medical and Emergency Services said that this drug is used in several countries worldwide, including European countries in some hospitals, which have already been included as part of their standard treatment of patients with covid-19.

Among all these treatments that are going to be used there are 1,666 in total, we will have two groups mainly where Remdesivir and Baricitinib will be used with Remdesivir and Dexamethasone, this we will already have an entire study implemented that is already it has the one we have been studying in, “Avalos Bracho added.

The general director of Provision of Medical Services and Emergencies, assured that this measure has been studied for several weeks and has been evaluated with other specialists worldwide.

In both the United Kingdom and the United States, it will be used and applied in mild to moderate patients with less than 10 days of symptoms within the hospital. This is going to start on February 18, next week in the four hospitals, we are at this moment that part of the medicine is already being distributed to the hospitals and we will start on February 18.

The Head of Government, Claudia Sheinbaum Pardo, recalled that Remdesivir is a drug that has already been approved by the Federal Commission for Protection against Sanitary Risks for use in a series of studies at the National Institute of Medical Sciences and Nutrition “Salvador Zubirán “and which is only used at the hospital level.

* In the following link you will find the latest news

Visit our last minute

* Also check out our Galleries

Visit our Galleries

** mca **

.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.